Vaccine

NeuralCure AI Launches the First Diagnostic & Digital Twin OS for Preventative Care Clinics

Powering the $600B+ Patient-Led Healthcare Revolution DENVER, June 19, 2025 /PRNewswire/ -- NeuralCure AI today announced the official launch of its…

6 months ago

The Department of Health – Abu Dhabi and Sanofi Forge Strategic Alliance to Accelerate the Development of New Global Vaccines in Abu Dhabi

On the sidelines of a high-level US visit focused on healthcare innovation ABU DHABI, UAE, June 18, 2025 /PRNewswire/ --…

6 months ago

IMUNON Presents Positive Phase 2 Translational Data of IMNN-001 in Advanced Ovarian Cancer at ESMO Gynaecological Cancers Congress 2025

ASCO 2025 overall survival data bolster IMNN-001’s potential in advanced ovarian cancer, supported by robust translational results at ESMO Results…

6 months ago

Kontakt.io Launches Temperature Monitoring Solution for Critical Healthcare Supplies

Cloud-based solution monitors temperature and humidity of refrigerators and regulated rooms with real-time alerts to ensure the safety and effectiveness…

6 months ago

C-Path’s New Paper in Nature Reviews Drug Discovery Highlights How to Maximize the Regulatory Impact of Consortium-Based Projects

BRUSSELS and AMSTERDAM, June 16, 2025 /PRNewswire/ -- The Innovative Health Initiative (IHI) and Critical Path Institute® (C-Path) today announced…

6 months ago

Merck Manuals Launches AI-powered Search Tool, Providing Enhanced Access to Trusted Medical Information and Resources

RAHWAY, N.J., June 16, 2025 /PRNewswire/ -- Merck Manuals, a comprehensive digital health resource, announced today it has launched a…

6 months ago

Wingcopter Leverages Ansys Technology to Scale Drone Delivery of Medical Supplies

Wingcopter refines its drone designs with simulation, increasing flight distance while retaining payload capacity and delivering essential supplies faster / Key…

6 months ago

BioNTech Announces Strategic Transaction to Acquire CureVac in Public Exchange Offer

Acquisition will strengthen the research, development, manufacturing and commercialization of mRNA-based cancer immunotherapy candidates, marking BioNTech’s next key milestone in…

6 months ago

BioNTech Announces Strategic Transaction to Acquire CureVac in Public Exchange Offer

Acquisition will strengthen the research, development, manufacturing and commercialization of mRNA-based cancer immunotherapy candidates, marking BioNTech’s next key milestone in…

6 months ago